Firm Profile > Dechert LLP > New York , United States
Dechert LLP Offices
1095 AVENUE OF THE AMERICAS
NEW YORK, NY 10036-6797
- Profile > Dechert LLP > Philadelphia
- Profile > Dechert LLP > Philadelphia (Latin International Profile)
- Profile > Dechert LLP > (Latin International Profile)
Dechert LLP > The Legal 500 Rankings
International litigation Tier 1
Dechert LLP is 'excellent' at handling complex multi-jurisdictional litigation matters, where it regularly advises investment funds, corporations and sovereign bodies. Indeed, the team is ‘brilliant, dedicated to its clients and is certainly a tier-one firm’, according to one client. Dennis H Hranitzky, who is co-head of the firm's international and insolvency litigation group in New York, is 'very sharp and very strategic’; he is currently advising funds managed by Argentem Creek Partners LP in litigation and Chapter 15 insolvency proceedings relating to defaulted bonds. Department co-head Gary Mennitt is also recommended. In Philadephia, Michael McGinley joined the group having acted as associate counsel to the President in the White House Counsel's Office.
Merger control Tier 1
Dechert LLP 'is the gold standard for outside counsel', according to one client. The antitrust team is 'responsive, creative, practical and informed' and operates under the joint leadership of Steven Bizar and Michael Weiner in Philadelphia and New York, respectively. In recent highlights, Washington DC-based Mike Cowie is representing CVS Health in its proposed acquisition of health insurer Aetna as well as in its sale of its RxCrossroads unit to McKesson. Fresenius appointed the group to oversee its acquisition of NxStage, and counsel Gregory Luib - who sits in Washington DC - was part of the team which advised American Airlines on its extended partnership with Qantas. Also notable is Craig Falls, who has recently assisted clients in the manufacturing and construction space. Rani Habash was recently promoted to partner in Washington DC, while Paul Denis retired.
Dechert LLP's 'practical and pragmatic' team is in 'a class of its own when it comes to registered funds'. The group is 'able to handle a myriad of issues and can martial experts who know the law in various jurisdictions'. Based in the New York office, Allison Fumai ('a rock star' with 'deep knowledge of the ETF industry'), Richard Horowitz, Jeremy Senderowicz and Stuart Strauss provide ongoing advice to Morgan Stanley's mutual and closed-end funds. In Washington DC, Robert Helm is 'a true business consigliere', Douglas Dick is 'thoughtful and pragmatic', and Thomas Bogle is 'intelligent, astute and very responsive'; Brenden Carroll and Stephen Cohen are also key contacts. Boston-based John O’Hanlon advises a large mutual fund complex on regulatory issues and ETF launches. Stephanie Capistron, Christopher Harvey, Geoffrey Kenyon and Christopher Christian are also key names in the Boston office. Harvey and Helm jointly lead the practice. Other clients include MainStay Funds and Deutsche Bank ETFs.
The team at Dechert LLP has 'a clear understanding of market practices' and provides 'creative structuring advice' particularly on CMBS transactions and CRE CLOs. Key figures in the team include practice head Richard Jones and Laura Swihart, who are singled out for their 'hands-on approach' and 'practical guidance'. Swihart and Devin Swaney act for Freddie Mac in MBS offerings, which totaled approximately $50bn in 2018, and Jones, who splits his time between Philadelphia and New York, advised a real estate finance company on one of the largest CRE CLOs to be issued since the 2008 financial crisis. Also in the CLO space, Charlotte-based John Timperio advised Mariner Investment Group on multiple new-issue CLOs, and also acted for Golub Capital in a series of middle-market CLO transactions. Another name to note in the Charlotte office is Christopher Duerden, who has gained recognition among his peers for his work in middle-market and broadly syndicated CLOs. Sean Solis left for Milbank, but Matthew Hays joined the Chicago office from Kirkland & Ellis LLP.
Dechert LLP's antitrust team recently secured a full victory for egg producer RW Sauder in a class action brought by direct purchasers claiming the client - and 12 other producers - conspired to reduce the domestic supply of eggs. George Gordon and Christine Levin, who are based in Philadelphia, defended Endo Pharmaceuticals in 'reverse payment' litigation brought by the FTC as a challenge to a patent settlement including a 'no-authorized generic' provision. A key name to note in New York is Ethan Litwin, who represented American Airlines in a series of class actions claiming the major airlines colluded to coordinate passenger seat capacity. Philadelphia-based Steven Bizar and New York-based Michael Weiner spearhead the firm's global antitrust department. Rani Habash was recently promoted to partner in the Washington DC office.
The group at Dechert LLP, which is chaired by Chicago-based David Kistenbroker and New York-based David Kelley, specializes in securities matters, as well as corporate governance and FCPA issues, congressional and internal investigations, US export controls and economic sanctions. Andrew Levander and Benjamin Rosenberg in New York are defending the director of a Hong Kong-based NGO, Dr Chi Ping Patrick Ho, in a criminal prosecution for alleged violations of the FCPA and money laundering charges relating to the bribery of Chadian and Senegalese government officials for the benefit of a Chinese energy company. Alongside Neil Steiner, Levander and a number of associated entities in multiple government agency investigations concerning the purchase of two not-for-profit nursing homes, which were promptly closed and sold to a luxury real estate developer, allegedly removing a deed restriction on the property; ultimately the client was cleared of any wrongdoing. Cathy Botticelli, Vincent Cohen are the names to note in Washington DC, and New York-based Jonathan Streeter is also recommended. In Philadelphia, the bench was greatly strengthened by the arrival of Michael McGinley, who joined the firm in April 2018 after serving as special assistant and associate counsel to President Trump.
E-discovery Tier 2
Dechert LLP's team is called upon by clients to provide e-discovery advisory and support services, particularly involving challenging time constraints, in a vast array of litigation and investigation matters. Clients particularly praise the firm for its experience in, and familiarity with, the European market. The group is led by experienced trial attorney Ben Barnett in Philadelphia ('without peer'), who is advising Airbus on a number of issues, including the launch of its open source aviation data platform, Project Skywise, in which he is drawing on his expertise in big data issues. Also based in Philadelphia, Matt Tate is another name to note for multi-jurisdictional e-discovery.
General commercial disputes Tier 2
The 'exceptional trial lawyers and litigators' at Dechert LLP 'combine technical excellence, outstanding relationship management and superior execution in the courtroom'. The litigation department's sub-practice areas include consumer class actions, financial services disputes and product liability and mass tort litigation; in the latter field, the firm recently hired a team of lawyers including three partners from Quinn Emanuel Urquhart & Sullivan, LLP. In other notable moves, commercial litigator David Stern joined the Los Angeles office from Hughes Hubbard & Reed LLP, and Michael McGinley joined in Philadelphia after serving as associate counsel and special assistant to the President in the White House Counsel's Office. Star litigators at the firm include securities fraud litigation expert Linda Goldstein in New York, William Oxley, managing partner of the Los Angeles office, and Washington DC-based Christina Sarchio, who recently secured dismissals for Apple in class action cases that alleged violations of a New Jersey consumer protection statute. Matthew Larrabee heads the department from New York.
International tax Tier 2
Dechert LLP's international tax practice handles matters for a range of financial services firms, asset managers and investment funds, and represents some of the largest funds as well as small and mid-size funds. Joshua Milgrim leads the 'seamless' team out of New York and led advice to GIC in connection with the strategic partnership between a Blackstone-led consortium (including Blackstone, Canada Pension Plan Investment Board and GIC) and Thomson Reuters for Thomson Reuters’ Financial & Risk business, valued at $20bn; Daniel Dunn also worked on this matter. Steven Clemens is representing FS/KKR Advisor (as investment adviser) as well as FS Investment Corporation (FSIC) and Corporate Capital Trust (CCT) in connection with the merger of FSIC and CCT, a deal valued at $10.8bn. Alongside Clemens, Adrienne Baker in Boston is representing Barings in connection with the externalization of investment management of Triangle Capital Corporation, a business development company, through which Barings will become the investment adviser to Triangle. New additions to the team include William Cejudo, who joined in Washington DC in May 2018 from Clifford Chance. Joseph Riley joined in New York in October 2017 from Willkie Farr & Gallagher LLP. Richard Wild has retired. Andrew Bloom departed in June 2018 to head tax strategy at Golub Capital.
Product liability, mass tort and class actions: pharmaceuticals and medical devices - defense Tier 2
Highly regarded in the pharmaceutical space, Dechert LLP is particularly experienced in handling product liability, mass tort and class actions for manufacturers and distributors. Jointly led by New York-based Sheila Birnbaum and Mark Cheffo, the team is representing Purdue Pharma as national counsel in over 1,400 cases regarding its prescription opioid medication, and is defending Pfizer as lead national counsel in litigation relating to the antidepressant Zoloft, which allegedly causes birth defects in children when taken during pregnancy. The practice group also continues to represent AbbVie in national product liability litigation involving testosterone replacement therapy AndroGel, including an MDL in Chicago in which Nathan Hoffman takes the co-trial counsel role. Moreover, the team is acting as lead appellate counsel for Johnson & Johnson in the mass tort litigation claiming personal injury from use of anti-psychotic medication Risperdal. Philadelphia-based Ben Barnett and Douglas Fleming in New York are other key members of the practice group.
Real estate Tier 2
Dechert LLP's practice covers commercial real estate finance, as well as the acquisition and sale of commercial real estate debt products. , while the firm also advises on loan origination, acquisitions and dispositions, securitizations, restructuring, commercial mortgage-backed securities (CMBS) and bankruptcy matters. The firm's client base includes issuers, underwriters, loan sellers, servicers, operating advisors and investors. New York-based Laura Swihart and Devin Swaney continue to act for key client Freddie Mac, and this year advised on around 50 deals with an aggregate value of $50bn. Swaney also advised First Foundation Bank as a mortgage loan seller in the securitization of loans secured by multifamily properties. Philadelphia-based Richard Jones and Charlotte-based Stewart McQueen advised The Bancorp on a $304m CMBS deal sponsored by The Bancorp Bank, a Delaware state chartered commercial bank. Another highlight included advising Blackstone Mortgage Trust on a $1bn collateralized loan obligation, while the firm also also acted for Citibank and Goldman Sachs on the $1.9bn refinancing of loans secured by luxury Bahamas resort Atlantis Paradise Island. Philadelphia-based Jason S Rozes, David Forti and New York-based Krystyna Blakeslee are also recommended. Newly promoted partners include Boston-based Christopher Desmond, Samuel Gilbert; Philadelphia-based Gennady Gorel, Kenneth Hackman and New York-based Matthew Fischer. Matthew Hays joined as partner in the Chicago office from Kirkland & Ellis LLP. Kahlil T Yearwood left the firm for Gibson, Dunn & Crutcher LLP. Other clients include Bank of America Merrill Lynch, Barclays, BlackRock, Credit Suisse and Goldman Sachs.
Dechert LLP has securities litigators in offices across the US and frequently handles class actions, shareholder derivative suits, mutual fund litigation, broker-dealer disputes and regulatory enforcement proceedings. The 'very likable' David Kistenbroker, who practices in both New York and Chicago, is global co-chair of the trial, investigations and securities group. He acted for Anavex Life Sciences Corporation and its officers in a 10b5 case that alleged false and misleading statements were made about the efficacy of the company’s experimental Alzheimer’s drug; Joni Jacobsen in Chicago also played a key role in that case. The same team also acted for Antares Pharma Inc in several cases, including a suit alleging that the company provided insufficient information to the FDA in support of Xyosted and overstated its approval prospects. In New York, firm chairman Andrew Levander, who handled a 33 Act claim for CHC Group, and global litigation head Matthew Larrabee are recommended, as is Michael Kichline in Philadelphia.
Dechert LLP is well regarded for searching and clearance matters as well as prosecution and portfolio management. Glenn Gundersen and Jeffrey Plies chair the practice, which notably represents Apple. In a recent highlight, Gundersen advised Willis Towers Watson on a wide range of trademark-related matters, including infringement and enforcement issues. Jennifer Insley-Pruitt and Spencer Joffrion are new arrivals, joining from Fross Zelnick Lehrman & Zissu, P.C. and Cravath, Swaine & Moore LLP respectively.
‘Collaborative, involved, professional and prompt’, Dechert LLP attracts praise for ‘seeking to understand the client’s business to provide a value-add service’. The group, which acts for corporate issuers and investment banks, is particularly prominent in advising business development companies and life sciences clients on equity deals. Among its recent highlights, Philadelphia-based private equity specialist Kenneth Young advised Corporate Capital Trust, a business development company, on its NYSE listing. New York-based group co-chair David Rosenthal (‘a trusted and valued advisor’) acted alongside Philadelphia’s Gregory Schernecke to advise Aquestive Therapeutics on its $67.5m IPO. Other key contacts include Boston-based department co-chair Thomas Friedmann, Philadelphia-based James Lebovitz and business development company specialist Harry Pangas, who recently joined in Washington DC from Eversheds Sutherland.
The team at Dechert LLP was recently strengthened by the addition of fiduciary compliance and prohibited transaction expert Steven Rabitz, who joined the New York office from Stroock & Stroock & Lavan LLP. Rabitz and executive compensation expert Andrew Oringer acts for a number of global financial services firms in fund structuring mandates and related issues requiring compliance with ERISA fiduciary standards. Co-head David Jones sits in the Philadelphia office alongside Eric Rubin, and advises public and private corporations, private equity investors and hedge funds on 280A and 409A tax compliance issues in the context of M&A. Standout transactions include acting for Actua Corporation in its $549m aggregate subsidiary sale, and advising Differential Brands Group on the $1.4bn majority acquisition of Hong Kong-listed licensing business Global Brands Group Holding. New York-based Stephen W Skonieczny is another name to note. Additional clients include Court Square Capital Partners, Credit Suisse Securities, FMC Corporation and Cerberus Capital Management.
Healthcare: life sciences Tier 3
The ‘highly creative’ practice at Dechert LLP is co-headed by Andrea L C Reid in Boston and David S Rosenthal in New York, who focus on IP and corporate work respectively. Reid advised clinical-stage biopharmaceutical company PureTech Health on IP-related aspects of its deal with Hoffman-La Roche to advance its milk-derived exosome platform technology for the oral administration of Roche’s antisense oligonucleotide platform. Rosenthal has assisted Egalet with an asset purchase agreement to acquire four FDA-approved, non-narcotic pain products from Iroko. Product liability litigators Sheila Birnbaum and Mark Cheffo, who joined the New York office from Quinn Emanuel Urquhart & Sullivan, LLP in July 2018, have been acting for Purdue in over 1,400 cases related to its prescription opioid pain medications. Patent specialist Chad Davis from Goodwin is another recent arrival in Boston. The ‘incredible’ Carl Morales in New York, who is experienced in developing and prosecuting patent portfolios for FDA-approved or soon-to-be approved drug products, is also recommended.
M&A litigation: defense Tier 3
Dechert LLP has a broad client base of acquirers, sellers, bidders, directors, special committees, investment banks, venture capitalists, individual investors, private equity firms, hedge funds and other stakeholders for deal-related litigation in both federal and state courts throughout the US, including the Delaware Court of Chancery. David Kistenbroker leads the practice from Chicago, where Joni Jacobsen is also highly recommended. In Dagenbach v Bravo Brio Restaurant Group, Inc, et al, they both acted for Bravo Brio in a putative class action that alleged deficiencies in the company's proxy materials, purportedly in violation of Section 14(a) of the '34 Act. The case was dismissed and the merger proceeded as planned. In Berger v Ecolab, et al in the Appellate Court of Illinois, they are acting for Swisher Hygiene, which is alleged to have breached its fiduciary duties by approving the sale of assets to Ecolab. After a tough courtroom battle, they also prevailed in In re Talmer Bancorp Shareholder Litigation, which is now on appeal.
Private equity buyouts Tier 3
Dechert LLP has further elevated itself in the private equity arena thanks to a series of headline and high-value transactions. Clients highlight the 'best-in-class' team's abilities in 'important and complex deals', where it provides 'valuable and insightful advice', 'a balanced commercial point of view' and a 'seamlessly integrated deal team'. It delivers a 'quick turn-around, responsiveness, precision and good internal communications across disciplines', and is praised for its 'understanding of investment parameters and risk tolerance combined with knowledge of the marketplace'. Building on its middle to upper-middle market credentials, it advised GIC on a strategic partnership between a Blackstone-led consortium (including GIC) and Thomson Reuters for the consortium to acquire a 55% stake in Refinitiv, the newly created entity to hold Thomson Reuters’ Financial & Risk (F&R) business. It also advised SK hynix, a Korean chipmaker, as part of a Bain Capital-led consortium which acquired Toshiba’s memory chip business for $18bn. It remains active in its classic middle to upper-middle market space and advised long-term client Court Square Capital Partners on the $2.02bn sale of Rocket Software to Bain Capital. Other clients include Bregal Partners, Centre Partners, Certares, MSD Partners and One Equity Partners. Chair of the global private equity practice Mark Thierfelder is 'very quick at understanding the issue', has 'enormous expertise', 'provides great insights and advice, is a shrewd and effective negotiator, is able to quickly staff appropriate resources, and is always responsive and available'. Philadelphia's Geraldine Sinatra is another senior member of the practice, as are Naz Zilkha, Markus Bolsinger, who is 'a good overall adviser', and Philadelphia partner Ken Young. Christian Matarese is 'a great young partner' and Gareth Clark is 'very knowledgeable, responsive, hard working and dedicated'. Jonathan Kim, 'an exceptional attorney' and Washington DC partner Bernado Piereck are 'terrific to work with'. Sarah Kupferman is 'a fantastic senior associate who runs transactions with confidence and will be a phenomenal M&A partner'. All partners are based in New York unless stated otherwise.
Dechert LLP is well known for representing pharmaceutical companies in chemical exposure claims, and also has experience in water contamination matters. Sheila Birnbaum and Mark Cheffo, who jointly head the team from New York, are defending Pfizer in product liability litigation relating to the antidepressant Zoloft, which allegedly causes birth defects in children when taken during pregnancy; the duo is also acting for Purdue Pharma in multiple cases concerning opioid medication. Los Angeles-based William Oxley continues to act as lead trial counsel for Union Carbide in asbestos litigation across the US. Nathan Hoffman in Chicago and Hope Freiwald in Philadelphia are also recommended.
Alternative/hedge funds Tier 4
Dechert LLP's 'responsive and knowledgeable' team advises a range of leading managers across the spectrum of fund formation and regulatory issues, and is particularly strong in cross-border work. Practice head David A Vaughan operates from both the New York and Washington DC offices; New York-based Matthew Kerfoot is well versed in assisting clients with financing mandates. Timothy Spangler, who is based in the Orange County office, has expertise in cryptocurrency-related funds work. Timothy Clark is another key name in the New York office.
Capital markets: debt Tier 4
Acting primarily for issuers, Dechert LLP is noted as ‘a leader in advising business development companies’, and is also well known in the life sciences sector. Recent highlights included James Lebovitz, who splits his time between Philadelphia and New York, advising a business development company on a $500m senior notes offering. In a high-profile multi-jurisdictional deal, Philadelphia partners William Lawlor and Ian Hartman advised Crown Holdings on two private placements of notes worth €335m and €500m respectively, which were issued by its French subsidiary. The team also advised Crown on a $875m private placement of notes issued by US subsidiaries. Boston-based Thomas Friedmann and New-York based David Rosenthal co-chair the corporate finance and capital markets practice.
‘Business-oriented, committed and knowledgeable’, according to one source, Dechert LLP’s capital markets practice ‘works closely with the client to provide an active and prominent voice in internal dialogues’. The group, which is well weighted between issuer and manager mandates, attracts particular praise as ‘a specialist advisor to business development companies’; it is also well versed in life sciences matters. In a significant cross-border highlight, Philadelphia-based partners William Lawlor and Ian Hartman advised Crown Holdings on two euro-denominated private placements of notes worth a combined €835m (issued by a French subsidiary of Crown) and a simultaneous $875m private placement of notes (issued by US subsidiaries of Crown) — the team was supported by lawyers in London, Paris and Luxembourg. Boston-based Thomas Friedmann, who advised PennantPark Floating Rate Capital on its $138.6m notes offering in Israel, and New York-based David Rosenthal, who ‘seeks to understand the client’s business’, jointly lead the department.
Dechert LLP’s high-yield debt practice is mainly active on behalf of issuers, with its client roster dominated by life sciences companies and permanent capital vehicles. The practice group, commended by sources for its ‘collaborative and business-focused approach’, can also draw on its global network for support in multi-jurisdictional matters. In Philadelphia, Stephen Leitzell recently advised B&G Foods on a $400m senior notes offering. New York-based life sciences expert David Rosenthal and Boston-based Thomas Friedmann co-chair the department.
Commercial lending Tier 4
Dechert LLP has a strong bench of 'very diligent and detail-oriented professionals, who are responsive and constructive' to borrowers and lenders on all layers of the capital structure. In relation to its experience in corporate acquisition financings, the firm's 'market knowledge is unsurpassed in middle market lending', which clients feel is 'invaluable in negotiating covenants'. The team also has good experience in fund finance, and regularly counsels direct lenders on their investments. Recently it advised consumer packaging company Crown Holdings on the financing for its $3.9bn acquisition of Signode Industrial Group Holdings from the Carlyle Group. Other highlights included representing Differential Brands Group, on the financing for its $1.4bn purchase agreement with Hong Kong's Global Brands Group Holding, to acquire a significant part of its North American licensing business. Practice head Scott M Zimmerman is 'a star', who 'combines true market knowledge with practicality and sound advice'. Other key figures include highly rated fund finance expert Jay R Alicandri, the 'outstanding' Jeffrey M Katz, and Sarah B Gelb, who is based in the firm's Philadelphia office.
The team at Dechert LLP is co-chaired by David Jones in Philadelphia and Andrew Oringer, the latter of whom advises on ERISA matters for clients including Credit Suisse Securities, Actua, Cerebus Capital Management and FMC. Oringer also leverages his fiduciary Title 1 expertise, acting as primary counsel to a client roster of investment banks and managers, mutual funds and trust companies regarding changes to the DOL’s fiduciary rule (and subsequent repeal). Having recently joined from Stroock & Stroock & Lavan LLP, Steven Rabitz brings even more experience to the team’s ERISA practice and is instructed by clients from the investment management sector. Partners are based in New York unless otherwise stated.
International arbitration Tier 4
Dechert LLP is noted for its 'international focus' and its 'excellent commercial approach, which enables the best results' for its clients. Washington DC-based department co-head Arif H. Ali has vast expertise in investor-state arbitration, particularly in the energy and oil and gas sectors; Ali is representing MOL Hungarian Oil and Gas against the Republic of Croatia as lead counsel under UNCITRAL arbitration rules. Further, 'superstar' Érica Franzetti stands out for her 'extremely well-versed' approach in high-stakes international disputes. In addition to its corporate client base, the 'diverse' practice group acts for a litany of sovereigns, including the Republic of Colombia, the Republic of Ecuador and the Republic of Poland.
International trade Tier 4
Strengthened by the arrival in April 2018 of the 'superb' Amanda DeBusk and the 'proactive and balanced' Melissa Duffy from Hughes Hubbard & Reed LLP, particularly on the export controls and economic sanctions front, Dechert LLP's growing international trade offering is an increasingly attractive proposition, both for institutional clients (including many of its impressive roster of funds clients) and on a standalone basis. Both DeBusk and Duffy provide sanctions and export controls counseling to global automotive heavyweight Ford Motor Company; as the largest US investor in Russia, the advice has been particularly tailored to ensure it mitigates its exposure to the recently implemented Russian sanctions. As part of his broad broad-ranging trade practice, co-head Jeremy Zucker regularly handles CFIUS clearance work, which recently included advising (alongside the firm's Hong Kong office) SK Hynix, as part of a consortium, on the $18bn acquisition of Toshiba’s memory chip division. Counsel Sean Kane is also recommended. All named attorneys are based in Washington DC.
The ‘top-notch’ Dechert LLP is known for its international expertise and ‘seasoned professionals with vast restructuring and bankruptcy experience’. The firm ‘excels particularly in contentious, litigation-driven matters, as well as cross-border restructurings’. The ‘highly effective’ Allan Brilliant is ‘a go-to for creditors in contentious corporate restructurings, particularly in Latin America’. He leads the practice from New York alongside Michael Sage, who is representing the ad hoc holders of first lien notes issued by Momentive Performance Materials and BOKF, as first lien trustee, in relation to the Chapter 11 of Momentive and certain of its affiliates. The team is also acting for the international bondholder committee in the restructuring of Brazilian telecoms giant Oi and its subsidiaries; the committee agreed to the terms of a Brazilian restructuring plan, under which it converted its debt to shares of the company and committed to backstop a R$3bn rights offering.
US taxes: non-contentious Tier 4
Dechert LLP’s tax team is ‘very knowledgeable in the RIC space and will gladly provide both industry perspective as well as an authoritative view on topics of interest’. The practice is best known for its strong financial services and asset management expertise where it advises on the tax aspects of mid-market private equity funds transactions, structured finance and securitization. Steven E Clemens and Ari Zak (‘excellent tax advisors who are willing to explore and discuss options to aid in resolving the matter at hand’) are advising FS/KKR Advisor on the multibillion-dollar merger of FS Investment Corporation and Corporate Capital Trust. Joshua Milgrim acted for GIC in a strategic partnership between a Blackstone-led consortium and Thomson Reuters to acquire a 55% stake in the equity of a new corporation created to hold the Thomson Reuters’ Financial & Risk business. Daniel Dunn and Adrienne M Baker in Boston are also recommended. Securitization specialist William Cejudo joined in May 2018 from Clifford Chance. All lawyers are based in New York unless otherwise noted.
M&A: large deals ($1bn+) Tier 5
Dechert LLP's increasing global prominence and dedication to the private equity segment has further bolstered its standing in strategic M&A. Moreover, its commitment to developing an international antitrust team, its strong CFIUS credentials and its experienced tax groups in key money centers, has further enabled it to gain traction in cross-border M&A. The 'world-class' team 'is always thinking several steps ahead', 'anticipates key deal structuring issues and presents innovative solutions'. It consistently outperforms many top Wall Street firms, according to one client. It is 'very thorough' and delivers 'a quick turn around, responsiveness, precision and good internal communications across disciplines'. It has an especially fine record in financial services, life sciences and healthcare transactions. Clients include B&G Foods, Crown Holdings, Differential Brands Group and H&E Equipment Services. It advised SK hynix as part of a Bain Capital-led consortium that acquired Toshiba’s NAND flash memory and solid-state drive business for $18bn. It also advised Crown Holdings on its $3.91bn acquisition of Signode Industrial Group Holdings, the global provider of transit packaging systems and solutions, from The Carlyle Group. Mark Thierfelder, chair of the global corporate and securities practice, has played an anchor role in increasing the team's status globally and in New York especially; he is 'a truly excellent deal lawyer' and 'his strategic guidance is invaluable'. Philadelphia's William Lawlor heads the global corporate governance practice and is an experienced domestic and cross-border M&A expert, as is Philadelphia partner Ian Hartman. Jonathan Kim, Christian Matarese, Markus Bolsinger and Naz Zilkha are also highly rated. Derek Winokur is 'super smart, super hardworking, and a genuinely really nice guy', he 'presents savvy negotiating tactics and superior M&A technical advice' and 'knows how to manage a relationship to ensure win-win outcomes'. All partners are based in New York unless stated otherwise.
Dechert LLP's funds practice is noted for its expertise in handling funds subject to European regulation; for example, New York-based Carl de Brito represented Crescent Capital Group as a sponsor for a group of levered and unlevered direct lending funds organized through an Irish QIAIF structure. David Vaughan in Washington DC and Russel Perkins in New York are key names. Other clients include Waterous Energy Fund, Australis Partners and Bregal Sagemount.
Dechert LLP has significant capability across a wide spectrum of regulatory issues affecting traditional banks and asset managers, as well as the rapidly growing fintech sector. Jointly headed by senior counsel David Ansell and David Harris, the team is noted for its expertise in bank control issues and is regularly engaged by bank holding companies as well as funds to structure investments in a manner which is consistent and that potentially mitigates the strictures of the Volcker Rule. On the fintech front, as well as advising across a variety of standalone regulatory issues impacting on blockchain technology and cryptocurrencies, the team has developed a strong reputation advising marketplace lenders on investments made by traditional banks in order to enter the market, as well as regularly helping secure charters for marketplace lenders. Recent highlights include advising BitGo in connection with an equity investment by Goldman Sachs. The team was recently impacted by the departure of experienced practitioners Thomas Vartanian and Robert Ledig, who left to head up a new financial regulatory institute at a US law school. Named attorneys are based in Washington DC.
Dechert LLP > Firm Profile
Dechert’s lawyers work together to understand their clients’ most complex legal and business problems and efficiently deliver practical and innovative solutions all over the world.
Our clients face increasingly challenging times, from geopolitical uncertainty and the increasing scope of compliance requirements, to a proliferation of commercial and regulatory risks. We partner with businesses to navigate these situations, supporting clients in achieving their commercial goals. Our method is agile and intuitive.
We have some of the world’s leading lawyers advising on both domestic and cross-border matters. The firm is frequently retained to work on the most challenging transactions and disputes, and prides itself on its ability to deliver premium legal services and sound business judgment to its clients. We create strategies that protect both commercial and private interests with discretion and sensitivity.
Dechert lawyers bring to all of their assignments a focus on quality, responsiveness and value for money. We are driven by one key principle: exceptional client service.
We seek to recruit the best talent, and we are committed to ensuring that Dechert reflects the societies we live in. We strive every day to become a truly diverse and inclusive business.
Dechert fosters in all its employees a high-performance yet supportive culture, encouraging people to constantly improve our services and working practices.
Technology and innovation are central to the future development of our business, both in terms of client-facing products and internal resources that enable more cost-effective operations, such as innovations in project management, eDiscovery and client-specific extranets.
Dechert is dedicated to enabling access to justice. Our pro bono commitment is widely acknowledged as setting the standard for international law firms, with 85,000+ hours completed worldwide in 2018. Dechert is working towards Mansfield Rule certification, a measure of commitment to boosting representation of diverse lawyers in firm leadership.
|Financial services and Investment management||Gus Black|
|Financial services and Investment management||Christopher Harvey|
|Financial services and Investment management||Robert Helm|
|Corporate and securities||Mark Thierfelder|
|Complex commercial litigation||William Oxley|
|Complex commercial litigation||Christina Guerola Sarchio|
|Intellectual property||Martin Black|
|Intellectual property||Paul Kavanagh|
|Intellectual property||Jeffrey Plies|
|Financial restructuring||Allan Brilliant|
|Financial restructuring||Michael Sage|
|Global finance||Richard Jones|
|White collar defense and investigations||David Kelley|
|White collar defense and investigations||Neil Gerrard|
|White collar defense and investigations||Hector Gonzalez|
|Securities litigation||David Kistenbroker|
|Securities litigation||Joni Jacobsen|
|Securities litigation||Michael Kichline|
|Employee benefits/executive compensation/tax||Andrew Oringer|
|Employee benefits/executive compensation/tax||David Jones|
|Employee benefits/executive compensation/tax||Joshua Milgrim|
|Mr Jay R Alicandri||View Profile|
|Mr Stephen H Bier||View Profile|
|Ms Sheila L. Birnbaum||View Profile|
|Ms Krystyna M. Blakeslee||View Profile|
|Dr Markus P Bolsinger||View Profile|
|Mr Allan S. Brilliant||View Profile|
|Mr Mark S. Cheffo||View Profile|
|Mr Timothy M. Clark||View Profile|
|Mr Gareth Clark||View Profile|
|Mr Steven E Clemens||View Profile|
|Mr Robert A Cohen||View Profile|
|Mr Stephen T Cohen||View Profile|
|Mr Malcolm S Dorris||View Profile|
|Mr Craig P Druehl||View Profile|
|Mr Daniel M Dunn||View Profile|
|Mr Mauricio A España||View Profile|
|Mr Mauricio A. España||View Profile|
|Mr Matthew H. Fischer||View Profile|
|Mr Douglas E. Fleming III||View Profile|
|Ms Allison M Fumai||View Profile|
|Mr José-Manuel García Represa||View Profile|
|Ms Linda C Goldstein||View Profile|
|Mr Hector Gonzalez||View Profile|
|Mr Brian E Greer||View Profile|
|Mr Dennis H. Hranitzky||View Profile|
|Mr Dennis H Hranitzky||View Profile|
|Ms Jennifer Insley-Pruitt||View Profile|
|Mr Spencer C. Joffrion||View Profile|
|Mr Jeffrey M Katz||View Profile|
|Mr David N Kelley||View Profile|
|Mr Matthew K. Kerfoot||View Profile|
|Mr Jonathan Kim||View Profile|
|Mr Howard Kleinman||View Profile|
|Ms Samantha R Koplik||View Profile|
|Ms Sarah Kupferman||View Profile|
|Mr Matthew L Larrabee||View Profile|
|Mr Michael A Lehmann||View Profile|
|Mr Andrew J Levander||View Profile|
|Mr Christian A Matarese||View Profile|
|Mr George J Mazin||View Profile|
|Mr Matthew L Mazur||View Profile|
|Mr Gary J. Mennitt||View Profile|
|Mr Joshua Milgrim||View Profile|
|Dr Carl A. Morales||View Profile|
|Mr Jeff Norton||View Profile|
|Mr Andrew L Oringer||View Profile|
|Mr Russel G Perkins||View Profile|
|Mr Stephen S. Rabinowitz||View Profile|
|Mr Steven W. Rabitz||View Profile|
|Mr Joseph A. Riley||View Profile|
|Mr Benjamin E Rosenberg||View Profile|
|Mr Michael J Sage||View Profile|
|Mr Jeremy I. Senderowicz||View Profile|
|Mr Stephen W Skonieczny||View Profile|
|Mr Stuart Strauss||View Profile|
|Mr Jonathan R. Streeter||View Profile|
|Mr Devin M. Swaney||View Profile|
|Ms Laura Swihart||View Profile|
|Mr Mark E Thierfelder||View Profile|
|Mr Shmuel Vasser||View Profile|
|Mr Michael Weiner||View Profile|
|Mr Charles I Weissman||View Profile|
|Mr Barton J Winokur||View Profile|
|Mr Ari M. Zak||View Profile|
|Mr Nazim Zilkha||View Profile|
|Mr Scott M Zimmerman||View Profile|
|Mr Carl A. de Brito||View Profile|
Dechert LLP > Firm Profile
Dechert is a leading global law firm with 27 offices around the world. We advise on matters and transactions of the greatest complexity, bringing energy, creativity and efficient management of legal issues to deliver commercial and practical advice for clients.
History of the firm: Founded in Philadelphia in 1875, Dechert has advised on matters involving Latin America for more than three decades. Its international network of trusted local counsel is bolstered by the firm’s foreign lawyer program, where lawyers from Latin American relationship firms are seconded to Dechert and vice versa.
Main areas of practice: Corporate and securities: Dechert’s corporate lawyers have advised companies seeking to expand their traction both within and outside Latin America for more than three decades. The firm represents buyers, sellers and advisers in connection with mergers and acquisitions and joint ventures. Dechert also handles a full range of corporate finance transactions, including initial public offerings and follow-on equity offerings, Rule 144A and Regulation S offerings, rights offerings, tender and exchange offers, and sovereign debt offerings.
Financial restructuring: Dechert represents distressed companies, buyers of distressed assets, investors in debt, equity holders and creditors in every phase of the insolvency and corporate recovery lifecycle in Latin America. The firm focuses on achieving clients’ financial and business goals in the most expedient manner possible, including advocating on their behalf.
Financial services and asset management: Dechert offers a broad range of transactional and regulatory services to Latin American banks, broker-dealers, investment managers, insurance companies and other financial institutions. It works closely with local counsel to facilitate public and private offerings of foreign collective investment schemes across the region. The firm has assisted clients in listing exchange-traded funds on Latin American stock exchanges and facilitated the approval of shares/units of investment funds for sale to pension funds administrators in Chile and Peru.
Global investigations: Dechert has considerable experience investigating and advising on anti-corruption compliance issues in Latin America, as well as matters involving tax and accounting fraud, money laundering and insider trading. The firm brings particular expertise to bear on matters involving FCPA and UK Bribery Act compliance, and also advises on civil and cartel investigations.
International arbitration and litigation: Dechert lawyers have acted as counsel or arbitrator in landmark arbitration proceedings involving Latin American parties, acting for and against state parties, majority and minority shareholders in joint ventures, and independent contractors. The firm also advises clients regarding their rights and remedies under investment treaties and other international instruments.
Governments, global corporations, corporate and sovereign debt holders, hedge funds and other financial institutions rely on the firm’s international litigators to resolve their most intractable cross-border commercial disputes, whether before courts, administrative tribunals or regulatory bodies. Its recent experience includes handling cross-border insolvency, sovereign debt and other commercial disputes involving such countries as Argentina, Mexico, Panama, Peru and Nicaragua.
International trade: Dechert handles a wide range of international trade matters, including export controls, economic sanctions, trade embargoes, customs procedures, trade defense measures and national security reviews of foreign direct investment. The firm’s practitioners include former national and multinational officials, comprising regulators, compliance officers, enforcement agents, trade negotiators and public affairs experts.
|Corporate and securities||Howard Kleinman E: email@example.com|
|Financial restructuring||Allan Brilliant E: firstname.lastname@example.org|
|Financial services and asset management||Douglas Dick E: email@example.com|
|Global investigations||Neil Gerrard E: firstname.lastname@example.org|
|International arbitration||Eduardo Silva Romero E: eduardo.silvaromero@ dechert.com|
|International arbitration||Arif Ali E: email@example.com|
|International litigation||Dennis Hranitzky E: firstname.lastname@example.org|
|International trade||Amanda DeBusk E: email@example.com|
|International trade||Miriam Gonzalez E: firstname.lastname@example.org|
|International trade||Jeremy Zucker E: email@example.com|
Dechert LLP > Firm Profile
Chairman: Andrew J Levander
CEO: Henry N Nassau
Number of partners: 306
Number of other lawyers: 700
International Offices: Almaty, Austin, Beijing, Boston, Brussels, Charlotte, Chicago, Dubai, Dublin, Frankfurt, Hartford, Hong Kong, London, Los Angeles, Luxembourg, Moscow, Munich, New York, Orange County, Paris, Philadelphia, Princeton, San Francisco, Silicon Valley, Singapore, Washington, DC
Corporate & Securities: Howard Kleinman
Financial Restructuring: Allan Brilliant
Financial Services & Asset Management: Douglas Dick
Global Investigations: Hector Gonzalez
International Arbitration: Eduardo Silva Romero, Arif Ali
International Litigation: Dennis Hranitzky
International Trade: Amanda DeBusk, Jeremy Zucker
Dechert is a leading global law firm with 26 offices around the world. Dechert advises on matters and transactions of the greatest complexity, bringing energy, creativity and efficient management of legal issues to deliver commercial and practical advice for clients. Founded in Philadelphia in 1875, Dechert has advised on matters involving Latin America for more than three decades. The firm’s international network of trusted local counsel is bolstered by the firm’s Foreign Lawyer Program, where lawyers from Latin American relationship firms are seconded to Dechert and vice versa.
Main Areas of Practice:
Corporate & Securities:
For more than three decades, Dechert’s corporate lawyers have advised companies seeking to expand their traction both within and outside Latin America. The firm represents buyers, sellers and advisers in connection with mergers and acquisitions and joint ventures. It also handles a full range of corporate finance transactions, including initial public offerings and follow-on equity offerings, Rule 144A and Regulation S offerings, rights offerings, tender and exchange offers, and sovereign debt offerings.
Dechert represents distressed companies, buyers of distressed assets, investors in debt, equity holders and creditors in every phase of the insolvency and corporate recovery lifecycle in Latin America. The firm focuses on achieving clients’ financial and business goals in the most expedient manner possible, including advocating on their behalf.
Financial Services & Asset Management:
Dechert offers a broad range of transactional and regulatory services to Latin American banks, broker-dealers, investment managers, insurance companies and other financial institutions. It works closely with local counsel to facilitate public and private offerings of foreign collective investment schemes across the region. The firm has assisted clients in listing exchange-traded funds on Latin American stock exchanges and has also facilitated the approval of shares/units of investment funds for sale to pension funds administrators in Chile and Peru.
Dechert has considerable experience investigating and advising on anti-corruption compliance issues in Latin America, as well as matters involving tax and accounting fraud, money laundering and insider trading. It brings particular expertise to bear on matters involving FCPA and UK Bribery Act compliance. The firm also advises on civil and cartel investigations.
International Arbitration & Litigation:
Dechert lawyers have acted as counsel or arbitrator in landmark arbitration proceedings involving Latin American parties, acting for and against state parties, majority and minority shareholders in joint ventures, and independent contractors. The firm also advises clients regarding their rights and remedies under investment treaties and other international instruments. Governments, global corporations, corporate and sovereign debt holders, hedge funds and other financial institutions rely on the firm’s international litigators to resolve their most intractable cross-border commercial disputes, whether before courts, administrative tribunals or regulatory bodies. Dechert’s recent experience includes handling cross-border insolvency, sovereign debt and other commercial disputes involving such countries as Argentina, Mexico, Panama, Peru and Nicaragua.
Dechert handles a wide range of international trade matters, including export controls, economic sanctions, trade embargoes, customs procedures, trade defence measures and national security reviews of foreign direct investment. The firm’s practitioners include former national and multinational officials, comprising regulators, compliance officers, enforcement agents, trade negotiators and public affairs experts.
40+ including Dutch, English, French, Portuguese, Spanish.
Top Tier Firm Rankings
- International litigation
- Merger control
- Mutual/registered/ exchange-traded funds
- Structured finance: securitization
- Civil litigation/class actions: defense
- Corporate investigations and white-collar criminal defense
- General commercial disputes
- International tax
- Product liability, mass tort and class actions: pharmaceuticals and medical devices - defense
- Real estate
- Securities litigation - defense
- Trademarks: non-contentious (including prosecution, portfolio management and licensing)
- Capital markets: equity offerings
- Employee benefits, executive compensation and retirement plans: transactional
- Healthcare: life sciences
- M&A litigation: defense
- Private equity buyouts
- Product liability, mass tort and class actions: toxic tort - defense
- Alternative/hedge funds
- Capital markets: debt
- Capital markets: global offerings
- Capital markets: high-yield debt offerings
- Commercial lending
- Employee benefits, executive compensation and retirement plans: design
- International arbitration
- International trade
- Restructuring (including bankruptcy): corporate
- US taxes: non-contentious
- M&A: large deals ($1bn+)
- Private equity funds (including venture capital)
- Financial services regulation